Philip Morris International Inc. Update on Holding of Medicago Inc.
NEW YORK--(BUSINESS WIRE)--Sep. 18, 2013--
Philip Morris International Inc. (NYSE / Euronext Paris: PM) announced
today that Philip Morris Investments B.V. (PM Investments), an affiliate
of PMI, as part of the previously announced arrangement of Medicago Inc.
(Medicago), made on July 12, 2013, acquired 11,348,266 common shares of
Medicago for a consideration of CAD $13,163,989.
The 11,348,266 common shares were acquired pursuant to a prospectus
exemption contained in section 2.11 of Regulation 45-106 respecting
Prospectus and Registration Exemptions (Québec) and represent 4.13%
of the issued and outstanding common shares of Medicago. Following this
transaction, the holding of PM Investments in Medicago consists of
109,957,066 common shares representing 40% of all of the issued and
outstanding common shares of Medicago. The balance of 164,935,599 common
shares of Medicago, representing 60% of all issued and outstanding
common shares of Medicago, are owned by Mitsubishi Tanabe Pharma
Corporation (MTPC) and one of its subsidiaries.
This most recent acquisition of common shares was made for investment
purposes. Until Medicago ceases to be a reporting issuer, PMI may, in
accordance with applicable securities laws, make additional investments
in, or disposition of, securities of Medicago, including additional
purchases of Medicago common shares.
This press release is not an admission that MTPC and its affiliates and
subsidiaries own or control any described security or are a joint actor
with PM Investments or any of its affiliates.
Philip Morris International Inc.
Philip Morris International Inc. (PMI) is the leading international
tobacco company, with seven of the world’s top 15 international brands,
including Marlboro, the number one cigarette brand worldwide.
PMI’s products are sold in more than 180 markets. In 2012, the company
held an estimated 16.3% share of the total international cigarette
market outside of the U.S., or 28.8% excluding the People’s Republic of
China and the U.S. For more information, see www.pmi.com.
Source: Philip Morris International Inc.
Philip Morris International Inc. Investor Relations: New York:
+1 (917) 663 2233 Lausanne: +41 (0)58 242 4666 or Media: Lausanne:
+41 (0)58 242 4500
RECEIVE EMAIL ALERTS
ABOUT OUR MOBILE APP
Our Investor Relations mobile application provides simple, comprehensive and up-to-date access to PMI’s disclosed investor relations materials as well as to live and archived audio webcast playback of earnings calls and investor presentations.